ArticleAlzheimer's & dementia (New York, N. Y.)2018

Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine.

Maurizio Severino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.